Delivery Order SPE2DB20D3505-SPE2DB23FU2T2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,652.07 for the supply of Latuda 20 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,225.10 fixed-price delivery order is for the delivery of Latuda 80 mg tablets. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.94 delivery order is for the supply of Latuda 60 mg tablets and has a completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,588.80 firm fixed-price delivery order is for the supply of 20 mg Latuda tablets, a prescription medication. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS47N, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,025.40 firm fixed price delivery order is for the supply of the prescription medication Latuda 80 mg tablets. The contract has a completion date of March 6, 2023 and was awarded on March 5, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Latuda 20 mg tablets, a specialty pharmaceutical product, to support the medical supply needs of the Defense Logistics Agency (DLA) Troop Support Medical. The $1,226.03 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $21,924.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Latuda 20 mg tablets to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
- This Federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Latuda 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,437.51 and a period of performance through February 3, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,238.09, is a firm fixed price delivery order for the supply of LATUDA 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of LATUDA 120 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,749.94 delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 11, 2022, with an ultimate completion date of April 12, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU2T2Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Latuda 120 mg tablets. The $1,320.07 firm fixed-price contract has a completion date of June 16, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order falls under that larger IDC. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. The contract award was made through full and open competition, without any set-aside designations. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical products to various federal government agencies, particularly the military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/15/23 |